KELSEY PERFECT: Open Payments
NPI 1528515475 · PORTLAND, OR. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,089 in 52 payments from 17 companies in 2025. Trend: 2023 $1,297 · 2024 $1,075 · 2025 $1,089
Food & beverage: $1,089
| Company | Payments | Amount |
|---|---|---|
| Amgen Inc. | 17 | $287 |
| Novartis Pharmaceuticals Corporation | 9 | $241 |
| Xeris Pharmaceuticals, Inc. | 5 | $98 |
| Medtronic, Inc. | 4 | $65 |
| Novo Nordisk Inc | 2 | $54 |
| Corcept Therapeutics | 2 | $53 |
| Lilly USA, LLC | 2 | $50 |
| Madrigal Pharmaceuticals | 1 | $45 |
| ABBVIE INC. | 2 | $32 |
| SANOFI-AVENTIS U.S. LLC | 1 | $27 |
Products named: EVENITY, LEQVIO, GVOKE HYPOPEN, MINIMED 780G, Wegovy, Korlym, MOUNJARO, REZDIFFRA.
Industry payments across OR — which companies pay providers there.
